| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 23,372 | 20,529 | 16,461 | | Cost of Revenue | 6,724 | 6,833 | 5,788 | | | Gross Profit | 16,648 | 13,696 | 10,673 | | | Operating Expenses | | Research Development | 1,219 | 1,488 | 2,177 | | Selling General and Administrative | 2,178 | 2,159 | 1,951 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 13,252 | 10,049 | 6,546 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,176 | 1,031 | 647 | | Earnings Before Interest And Taxes | 14,428 | 11,080 | 7,192 | | Interest Expense |
-
|
-
| 1 | | Income Before Tax | 14,428 | 11,080 | 7,192 | | Income Tax Expense | 4,645 | 3,893 | 2,411 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,783 | 7,187 | 4,781 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 9,783 | 7,187 | 4,781 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,783 | $7,187 | $4,781 |
|
1.48% Nasdaq 
Income Statement
